South Korea
· Delayed Price · Currency is KRW OSTEONIC Statistics
Total Valuation
OSTEONIC has a market cap or net worth of KRW 126.99 billion. The enterprise value is 131.24 billion.
| Market Cap | 126.99B |
| Enterprise Value | 131.24B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OSTEONIC has 20.06 million shares outstanding. The number of shares has increased by 0.24% in one year.
| Current Share Class | 20.06M |
| Shares Outstanding | 20.06M |
| Shares Change (YoY) | +0.24% |
| Shares Change (QoQ) | -33.56% |
| Owned by Insiders (%) | 19.87% |
| Owned by Institutions (%) | 6.57% |
| Float | 16.06M |
Valuation Ratios
The trailing PE ratio is 19.52 and the forward PE ratio is 12.33.
| PE Ratio | 19.52 |
| Forward PE | 12.33 |
| PS Ratio | 3.02 |
| PB Ratio | 1.99 |
| P/TBV Ratio | 2.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 26.73 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.44, with an EV/FCF ratio of -51.37.
| EV / Earnings | 20.19 |
| EV / Sales | 3.12 |
| EV / EBITDA | 13.44 |
| EV / EBIT | 21.52 |
| EV / FCF | -51.37 |
Financial Position
The company has a current ratio of 2.98, with a Debt / Equity ratio of 0.34.
| Current Ratio | 2.98 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 2.20 |
| Debt / FCF | -8.40 |
| Interest Coverage | 5.08 |
Financial Efficiency
Return on equity (ROE) is 10.76% and return on invested capital (ROIC) is 4.71%.
| Return on Equity (ROE) | 10.76% |
| Return on Assets (ROA) | 4.16% |
| Return on Invested Capital (ROIC) | 4.71% |
| Return on Capital Employed (ROCE) | 7.90% |
| Revenue Per Employee | 219.35M |
| Profits Per Employee | 33.86M |
| Employee Count | 182 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 1.15 |
Taxes
In the past 12 months, OSTEONIC has paid 1.98 billion in taxes.
| Income Tax | 1.98B |
| Effective Tax Rate | 23.31% |
Stock Price Statistics
The stock price has increased by +27.16% in the last 52 weeks. The beta is 1.05, so OSTEONIC's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | +27.16% |
| 50-Day Moving Average | 6,973.20 |
| 200-Day Moving Average | 6,951.25 |
| Relative Strength Index (RSI) | 41.87 |
| Average Volume (20 Days) | 142,077 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSTEONIC had revenue of KRW 42.11 billion and earned 6.50 billion in profits. Earnings per share was 324.34.
| Revenue | 42.11B |
| Gross Profit | 20.93B |
| Operating Income | 6.10B |
| Pretax Income | 8.48B |
| Net Income | 6.50B |
| EBITDA | 9.76B |
| EBIT | 6.10B |
| Earnings Per Share (EPS) | 324.34 |
Balance Sheet
The company has 17.22 billion in cash and 21.47 billion in debt, giving a net cash position of -4.26 billion or -212.10 per share.
| Cash & Cash Equivalents | 17.22B |
| Total Debt | 21.47B |
| Net Cash | -4.26B |
| Net Cash Per Share | -212.10 |
| Equity (Book Value) | 63.89B |
| Book Value Per Share | 3,184.76 |
| Working Capital | 37.44B |
Cash Flow
In the last 12 months, operating cash flow was 4.75 billion and capital expenditures -7.31 billion, giving a free cash flow of -2.55 billion.
| Operating Cash Flow | 4.75B |
| Capital Expenditures | -7.31B |
| Free Cash Flow | -2.55B |
| FCF Per Share | -127.35 |
Margins
Gross margin is 49.70%, with operating and profit margins of 14.48% and 15.44%.
| Gross Margin | 49.70% |
| Operating Margin | 14.48% |
| Pretax Margin | 20.13% |
| Profit Margin | 15.44% |
| EBITDA Margin | 23.19% |
| EBIT Margin | 14.48% |
| FCF Margin | n/a |
Dividends & Yields
OSTEONIC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.24% |
| Shareholder Yield | -0.24% |
| Earnings Yield | 5.12% |
| FCF Yield | -2.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 24, 2020. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 24, 2020 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
OSTEONIC has an Altman Z-Score of 3.54 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.54 |
| Piotroski F-Score | 6 |